Compound for the Prevention Of Rosacea Inflammation
A topical application has the potential to be developed from this invention for rosacea patients.
Previously an increase in the number of mast cells has been associated with rosacea in patients. Building on this knowledge, UC San Diego researchers have found that a compound that is traditionally used to treat allergic disorders has the ability to block the activation of mast cells and in turn prevent the induction of skin rosacea.
9801848
State Of Development UCSD researchers have not only validated the efficacy of this compound in a murine model, but also have delineated its mechanism of action. Intellectual Property Info This technology is available for licensing. Related Materials Tech ID/UC Case 23458/2013-153-0 Related Cases 2013-153-0
美国
